[144] Jazz Pharmaceuticals, Inc. SEC Filing
Jazz Pharmaceuticals reported a Form 144 notice showing an insider intends to sell 3,731 shares of common stock on NASDAQ through ETRADE, with an aggregate market value of $417,872 and total shares outstanding reported as 60,658,809. The shares were acquired by restricted stock vesting on 08/07/2025 and the proposed sale date is listed as 08/08/2025. The filing states payment was for compensation and notes no securities sold in the past three months. The filer also certifies they are not aware of any undisclosed material adverse information.
- None.
- None.
Insights
TL;DR: Small insider sale from vested restricted stock; transaction size appears immaterial versus outstanding shares and meets Rule 144 disclosure requirements.
The 3,731-share sale equals an aggregate value of $417,872 as reported and originates from restricted stock vesting the day before the planned sale. Compared with the 60,658,809 shares outstanding cited in the filing, the position size is de minimis and is unlikely to move market metrics. The filer reports no sales in the prior three months, which reduces potential clustering of insider disposals in recent periods. This filing primarily serves regulatory transparency.
TL;DR: Disclosure is standard governance practice; the attestation and Rule 144 notice indicate compliance with insider-sale reporting obligations.
The Form 144 documents a routine disclosure: securities acquired via restricted stock vesting and proposed for sale through a broker. The form includes the standard attestation that the filer does not possess undisclosed material adverse information. There is no indication in the filing of a trading plan adoption date or other special arrangements, and the filing records no other recent sales by the reporting person, suggesting normal compliance with Rule 144 procedures.
FAQ
What securities does Jazz Pharmaceuticals (JAZZ) report for sale in this Form 144?
When were the reported shares acquired for the JAZZ Form 144?
What is the approximate sale date listed in the JAZZ Form 144?
Has the filer sold any Jazz Pharmaceuticals securities in the past three months?
What attestation does the filer make on this Form 144?
